The “other site???” Hell, I barely even look at this site. Why in the hell would I look at that one? Otherwise, you make a good point. It might be a good idea for you to send to your bank a screenshot of the watered-down Linked-In page that is displayed to people who don’t have Linked-In accounts. I’m sure they’ll disregard any concern about the SEC revoking QTMM’s registration. They’ll know it’s a forgone conclusion that this company that couldn’t fulfill its most basic obligation to its investors will have little problem salvaging the situation by filing for a new registration, since obviously paperwork, filing, accounting and basically every other skill that comes along with being an adult is their forte. And what could happen over the next 18 months to derail these optimistic expectations? The fact that QTMM couldn’t even make it from February to the end of June without a catastrophe derailing what appeared to be a simple task was a fluke. Who could have predicted that? They would have need a crystal ball, or a letter from the SEC telling them exactly what would happen, when it would happen and how to avoid it. When in the world has that ever happened? I’ll just listen to you and focus on what matters—a rumor that they’re growing based on data gleaned from an unpaid Linked-in subscription. I see the wisdom of that—or I will, once I get my sh*t straight.
The “other site???” Hell, I barely even look at this
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Celebrating Innovative Thought Leadership: TLFT 2025 Awards
Celebrating Innovative Thought Leadership Accenture, KPMG, and Elsevier have been honored for their groundbreaking accomplishments in thought leadership, showcasing their significant influence across brand development, social impact, and industry standards. Recognition at the TLFT 2025 Awards iResearch Services has proudly unveiled the winners of the prestigious TLFT 2025...
Continue Reading
Aquestive Therapeutics Boosts Stock Target After Event Insights
Aquestive Therapeutics made headlines back in 2024 with its stock getting a price target bump to $10 from H.C. Wainwright. This was right after they rolled out updates at a virtual investor event where they pitched their cutting-edge Adrenaverse technology. Traders were buzzing—was this the kind of news that’d drive shares up? Turns out, it was more than just fluff;...
Continue Reading
Valneva Collaborates with LimmaTech on Shigella Vaccine Study
Valneva Begins Clinical Trials for Innovative Shigella Vaccine Valneva SE, a prominent specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech firm, have recently marked a significant milestone in vaccine research. They announced the initial vaccination in a pivotal Phase 2b controlled human infection model (CHIM) study focused on their tetravalent...
Continue Reading
Innovative Vehicle Accessory Enhances Road Safety Efforts
Introducing a Revolutionary Vehicle Safety Accessory Every day, drivers encounter various challenges on the road, from navigating busy intersections to spotting pedestrians or hidden traffic signs. An innovative inventor recognized these challenges and developed the CORNER CAMERA, an inventive solution aimed at improving road safety for everyone. Understanding the CORNER...
Continue Reading
California Northstate University Celebrates Key Accreditation Milestone
California Northstate University Announces Full Accreditation California Northstate University (CNU) has achieved a significant milestone by securing full accreditation for its College of Medicine from the Liaison Committee on Medical Education (LCME). This achievement underscores CNU’s unwavering dedication to promoting educational excellence, innovation, and the...
Continue Reading